Johnson Financial Group, Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1477024
RACINE, WI
Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$66,561
-$84,369 QoQ
Shares Held
134
-60.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,506
of 1,735 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Johnson Financial Group, Inc. holds $2,424,373 across 21 Biotechnology names. VRTX ranks #3 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,250 | $2,026,504 | |
| 2 | EXEL |
Exelixis, Inc.
|
3,992 | $217,204 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
134 | $66,561 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
200 | $37,456 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
142 | $34,217 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
143 | $11,655 | |
| 7 | ABVX |
Abivax S.A.
|
62 | $8,262 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
49 | $4,776 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,561 | 134 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $150,930 | 338 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $166,382 | 367 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $253,782 | 648 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $188,764 | 424 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $525,544 | 1,084 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $849,696 | 2,110 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,438,336 | 7,393 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,236,980 | 6,906 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $432,221 | 1,034 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $407,296 | 1,001 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $339,741 | 977 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $375,487 | 1,067 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $235,987 | 749 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $46,493 | 161 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $46,615 | 161 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $35,223 | 125 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $32,621 | 125 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $27,450 | 125 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,673 | 125 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $25,203 | 125 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $26,861 | 125 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||